Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SMARCA4‐deficient rhabdoid tumours show intermediate molecular features between SMARCB1‐deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type
Mamy Andrianteranagna, Joanna Cyrta, Julien Masliah‐Planchon, et al.
The Journal of Pathology (2021) Vol. 255, Iss. 1, pp. 1-15
Closed Access | Times Cited: 21

Showing 21 citing articles:

Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer
Seok-Young Kim, Tamar A. E. de Weert, Marijn A. Vermeulen, et al.
Science Advances (2025) Vol. 11, Iss. 9
Closed Access | Times Cited: 1
SMARCA4 and SMARCA2 co-deficiency: An uncommon molecular signature defining a subset of rare, aggressive and undifferentiated malignancies associated with defective chromatin remodeling.
Natisha Field, Kristie-Ann Dickson, Najah T. Nassif, et al.
Cancer Letters (2024), pp. 217282-217282
Open Access | Times Cited: 7
Current and Emerging Therapeutic Approaches for Extracranial Malignant Rhabdoid Tumors
Karolina Nemes, Pascal D. Johann, Stefanie Tüchert, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 479-498
Open Access | Times Cited: 24
SMARCB1‐deficient malignant melanocytic uveal tumours: a new neural crest‐derived tumour entity with SMARCB1‐related germline predisposition
Joanna Cyrta, Julien Masliah‐Planchon, Owen Hoare, et al.
The Journal of Pathology (2025)
Open Access
Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with SMARCB1 Mutation: A Literature Review of a Rare and Aggressive Condition
Maria Fernanda Evangelista Simões, Alexandre André Balieiro Anastácio da Costa, Tullio Novaes Silva, et al.
Current Oncology (2022) Vol. 29, Iss. 2, pp. 411-422
Open Access | Times Cited: 13
Cellular context determines DNA methylation profiles in SWI/SNF‐deficient cancers of the gynecologic tract
F. Kommoss, Basile Tessier‐Cloutier, Leora Witkowski, et al.
The Journal of Pathology (2022) Vol. 257, Iss. 2, pp. 140-145
Closed Access | Times Cited: 13
NUT carcinoma and thoracic SMARCA4‐deficient undifferentiated tumour: facts and controversies
Akihiko Yoshida
Histopathology (2023) Vol. 84, Iss. 1, pp. 86-101
Open Access | Times Cited: 7
Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups
María-Jesús Lobón-Iglesias, Mamy Andrianteranagna, Zhi‐Yan Han, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Whole-genome characterization of myoepithelial carcinomas of the soft tissue
Joanna Cyrta, Joel Rosiene, Rohan Bareja, et al.
Molecular Case Studies (2022) Vol. 8, Iss. 7, pp. a006227-a006227
Open Access | Times Cited: 9
BRG1 establishes the neuroectodermal chromatin landscape to restrict dorsal cell fates
Jackson A. Hoffman, Ginger W. Muse, Lee Langer, et al.
Science Advances (2024) Vol. 10, Iss. 9
Open Access | Times Cited: 1
Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies—Therapeutic Vulnerabilities in Treatment-Resistant Subtypes
Yue Ma, Natisha Field, Tao Xie, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3068-3068
Open Access | Times Cited: 1
The role of cancer predisposition syndrome in children and adolescents with very rare tumours
Daniel Orbach, Ines B. Brecht, Nadège Corradini, et al.
EJC Paediatric Oncology (2023) Vol. 2, pp. 100023-100023
Open Access | Times Cited: 3
SWI/SNF‐deficient undifferentiated malignancies: where to draw the line†
Basile Tessier‐Cloutier, Claudia L. Kleinman, William D. Foulkes
The Journal of Pathology (2021) Vol. 256, Iss. 2, pp. 139-142
Open Access | Times Cited: 5
Epigenetic age acceleration is a distinctive trait of epithelioid sarcoma with potential therapeutic implications
Simon Haefliger, Olga Chervova, Christopher Davies, et al.
GeroScience (2024) Vol. 46, Iss. 5, pp. 5203-5209
Open Access
Additional Considerations on Aberrant BRG1 (SMARCA4) Expression in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT)
Joanna Cyrta, Riwan Brillet, Enora Laas, et al.
The American Journal of Surgical Pathology (2024) Vol. 48, Iss. 10, pp. 1335-1338
Open Access
Expanding the clinicopathologic spectrum and genomic landscape of tumors with SMARCA2/4::CREM fusions
Joanna Cyrta, Josephine K. Dermawan, Arnault Tauziède‐Espariat, et al.
The Journal of Pathology (2024) Vol. 264, Iss. 3, pp. 305-317
Closed Access
Clinicopathologic feature and treatment progress of high-grade ovarian neuroendocrine tumors
Qionghua He, Chenyan Wang, Da Wei Huang, et al.
Medical Oncology (2024) Vol. 42, Iss. 1
Closed Access
SMARCA4-associated malignant rhabdoid tumors: case report and literature review
Н. А. Андреева, E. I. Lyudovskikh, Д. М. Коновалов, et al.
Russian Journal of Pediatric Hematology and Oncology (2022) Vol. 9, Iss. 2, pp. 75-84
Open Access | Times Cited: 1
BRG1 establishes the neuroectodermal chromatin landscape to restrict dorsal cell fates
Jackson A. Hoffman, Ginger W. Muse, Lee Langer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Undifferentiated, Mixed and Other Tumours of the Ovary
David B. Chapel
Springer eBooks (2023), pp. 479-514
Closed Access
Importance of pharmacologic considerations in the development of targeted anticancer agents for children
Sridhar M. Veluvolu, Patrick J. Grohar
Current Opinion in Pediatrics (2022) Vol. 35, Iss. 1, pp. 91-96
Closed Access
Page 1

Scroll to top